Physician profile
Marco Lawandy
NPI 1730760620
$4,092.98
in general payments reported to CMS, 2019-2025
10 companies · $4,093 in 2025
The $4,093 reported for 2025 was more than what 93% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $4,093.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,619 · Travel and Lodging: $1,474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,619.07 |
| Travel and Lodging | $1,473.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,341.65 | 2025 | Wavewriter Alpha Prime 16, Intracept |
| Medtronic, INC. | $1,250.34 | 2025 | Intellis Adaptivestim, Synchromedii |
| Biotronik Nro, INC. | $332.51 | 2025 | Prospera |
| Abbott Laboratories | $278.47 | 2025 | Eterna, Proclaim |
| Spr Therapeutics, INC | $261.54 | 2025 | Sprint Pns System |
| Mml US, INC. | $229.56 | 2025 | Reactiv8 |
| Curonix LLC | $141.76 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Piramal Critical Care | $120.29 | 2025 | |
| Foundation Fusion Solutions, LLC | $101.91 | 2025 | |
| Globus Medical, INC. | $34.95 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marco Lawandy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.